Results 201 to 210 of about 49,613 (221)

Peripheral lymphocyte count defines the clinical phenotypes and prognosis in patients with anti‐MDA5‐positive dermatomyositis

Journal of Internal Medicine, 2023
To explore the role of peripheral lymphocyte count in phenotyping and prognosis prediction in dermatomyositis (DM) patients with anti‐MDA5 antibodies.
Qiwen Jin, Lijun Fu, Hongxia Yang, Xi-xue Chen, Sang Lin, Zhenguo Huang, Bao-xiang Gao, X. Tian, Wei Jiang, X. Shu, Xin Lu, Guochun Wang, Q. Peng   +12 more
semanticscholar   +1 more source

Characteristics of dermatomyositis patients with and without associated malignancy

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2021
Dermatomyositis belongs to the rare idiopathic, inflammatory myositis group. A previously postulated link between some cases of dermatomyositis and malignancy has been established in recent years. Criteria suggestive of a malignancy association are still
J. Lauinger, K. Ghoreschi, S. Volc
semanticscholar   +1 more source

Risk Prediction Modeling Based on a Combination of Initial Serum Biomarker Levels in Polymyositis/Dermatomyositis–Associated Interstitial Lung Disease

Arthritis & Rheumatology, 2020
To establish predictive models for mortality in patients with polymyositis/dermatomyositis–associated interstitial lung disease (PM/DM‐ILD) using a combination of initial serum biomarker levels.
T. Gono, K. Masui, N. Nishina, Y. Kawaguchi, A. Kawakami, K. Ikeda, Y. Kirino, Y. Sugiyama, Y. Tanino, T. Nunokawa, Y. Kaneko, Shinji Sato, Katsuaki Asakawa, T. Ukichi, S. Kaieda, T. Naniwa, Y. Okano, M. Kuwana   +17 more
semanticscholar   +1 more source

Neutrophil Extracellular Traps in Tissue and Periphery in Juvenile Dermatomyositis

Arthritis & Rheumatology, 2020
Neutrophils are key immune cells participating in host defense through several mechanisms, including the formation of neutrophil extracellular traps (NETs). This study was undertaken to investigate the role of neutrophils in juvenile dermatomyositis (JDM)
Bhargavi Duvvuri, L. Pachman, Gabrielle A Morgan, Amer M. Khojah, M. Klein‐gitelman, M. Curran, S. Doty, C. Lood   +7 more
semanticscholar   +1 more source

Autologous CD19‐Targeting CAR T Cells in a Patient With Refractory Juvenile Dermatomyositis

Arthritis & Rheumatology
The aim of this study is to report the safety and efficacy of CD19‐targeting chimeric antigen receptor (CAR) T cells in a child with refractory juvenile dermatomyositis (JDM).
R. Nicolai, P. Merli, P. Morán Álvarez, C. Bracaglia, F. del Bufalo, Emiliano Marasco, I. Caiello, G. Prencipe, M. Algeri, M. Cefalo, Marco Becilli, C. Quintarelli, M. Sinibaldi, L. Hanssens, Fabrizio De Benedetti, F. Locatelli   +15 more
semanticscholar   +1 more source

Clinical features and poor prognostic factors of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with rapid progressive interstitial lung disease

EJD. European journal of dermatology, 2019
Anti-melanoma differentiation-associated gene 5 (MDA5) antibody has been recognized to be significantly associated with a subset of dermatomyositis patients with rapidly progressive interstitial lung disease (RP-ILD).
S. Motegi, A. Sekiguchi, Sayaka Toki, C. Kishi, Y. Endo, M. Yasuda, H. Ikeuchi, T. Sakairi, Kenichiro Hara, K. Yamaguchi, T. Maeno, K. Hiromura, O. Ishikawa   +12 more
semanticscholar   +1 more source

Update on dermatomyositis in adults

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2020
Dermatomyositis (DM) in adults has a prevalence of 6–7 per 100,000 population per year. This dedicated compact overview was prepared due to an increasing incidence as well as an often underestimated systemic involvement and new developments in myositis ...
Nora Schlecht, C. Sunderkötter, Sabine Niehaus, D. Nashan   +3 more
semanticscholar   +1 more source

Muscle Expression of Type I and Type II Interferons Is Increased in Juvenile Dermatomyositis and Related to Clinical and Histologic Features

Arthritis & Rheumatology, 2019
To evaluate the expression of type I interferon (IFNα/β)– and type II IFN (IFNγ)–inducible genes in muscle biopsy specimens from patients with juvenile dermatomyositis (DM) and to correlate their expression levels with histologic and clinical features.
G. Moneta, D. Pires Marafon, E. Marasco, S. Rosina, M. Verardo, C. Fiorillo, C. Minetti, L. Bracci-Laudiero, A. Ravelli, F. De Benedetti, R. Nicolai   +10 more
semanticscholar   +1 more source

Dermatomyositis in a patient undergoing nivolumab therapy for metastatic melanoma: a case report and review of the literature.

Melanoma research, 2020
Checkpoint inhibitor immunotherapy is a transformative treatment for advanced malignancies, but can be associated with numerous immune-related adverse events (irAEs).
C. Kosche, M. Stout, J. Sosman, R. Lukas, Jennifer N. Choi   +4 more
semanticscholar   +1 more source